1 LATANOPROST | 530 of 1430 | 2710 prescriptions Less than 1% of all prescriptions | 2570 | 850 patients 35% of all patients | < 11 | |
2 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 150 of 1000 | 1320 prescriptions Less than 1% of all prescriptions | 1180 | 490 patients 20% of all patients | < 11 | |
3 TIMOLOL MALEATE | 430 of 1230 | 1300 prescriptions Less than 1% of all prescriptions | 1100 | 490 patients 20% of all patients | < 11 | |
4 BRIMONIDINE TARTRATE | 150 of 1000 | 1310 prescriptions Less than 1% of all prescriptions | | 470 patients 19% of all patients | < 11 | |
5 COMBIGAN (BRIMONIDINE TARTRATE/TIMOLOL) | 160 of 920 | 980 prescriptions Less than 1% of all prescriptions | 850 | 260 patients 11% of all patients | < 11 | |
6 DORZOLAMIDE HCL | 190 of 770 | 600 prescriptions Less than 1% of all prescriptions | 600 | 240 patients 10% of all patients | 240 patients 10% of all patients | |
7 AZOPT (BRINZOLAMIDE) | 240 of 540 | 280 prescriptions Less than 1% of all prescriptions | 280 | 140 patients 6% of all patients | 140 patients 6% of all patients | |
8 PREDNISOLONE ACETATE | 890 of 1360 | 360 prescriptions Less than 1% of all prescriptions | | 270 patients 11% of all patients | < 11 | |
9 ALPHAGAN P (BRIMONIDINE TARTRATE) | 220 of 690 | 470 prescriptions Less than 1% of all prescriptions | 470 | 110 patients 5% of all patients | 110 patients 5% of all patients | |
10 LUMIGAN (BIMATOPROST) | 550 of 920 | 310 prescriptions Less than 1% of all prescriptions | | 110 patients 5% of all patients | < 11 | |
11 SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TART) | 110 of 370 | 270 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 TRAVATAN Z (TRAVOPROST) | 470 of 760 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
13 KETOROLAC TROMETHAMINE | 340 of 730 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
14 ACETAZOLAMIDE | 80 of 190 | 250 prescriptions Less than 1% of all prescriptions | 250 | 170 patients 7% of all patients | 170 patients 7% of all patients | |